Growth Metrics

Vycor Medical (VYCO) Cash from Operations Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -7.20%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 132.40%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 6.69%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -35.67%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -84.38%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 122.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 185.96%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 16.00%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 28.60%
10 Vycor Medical - - 375,153.00 469.47%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 469.47%
Dec 31, 2025 202.48%
Sep 30, 2025 -791.76%
Jun 30, 2025 -45.80%
Mar 31, 2025 -1,526.02%
Dec 31, 2024 -795.01%
Sep 30, 2024 170.44%
Jun 30, 2024 507.41%
Mar 31, 2024 -92.34%
Dec 31, 2023 116.51%
Sep 30, 2023 80.63%
Jun 30, 2023 150.34%
Mar 31, 2023 131.25%
Dec 31, 2022 -206.04%
Sep 30, 2022 -23.00%
Jun 30, 2022 -132.54%
Mar 31, 2022 -130.62%
Dec 31, 2021 630.49%
Sep 30, 2021 61.89%
Jun 30, 2021 294.22%
Mar 31, 2021 1.29%
Dec 31, 2020 -224.17%
Sep 30, 2020 -936.27%
Jun 30, 2020 -261.44%
Mar 31, 2020 -91.66%
Dec 31, 2019 -81.50%
Sep 30, 2019 154.35%
Jun 30, 2019 88.32%
Mar 31, 2019 87.52%
Dec 31, 2018 114.65%
Sep 30, 2018 64.58%
Jun 30, 2018 -1,470.03%
Mar 31, 2018 40.42%
Dec 31, 2017 -58.41%
Sep 30, 2017 -3,542.37%
Jun 30, 2017 96.33%
Mar 31, 2017 -21.35%
Dec 31, 2016 -19.08%
Sep 30, 2016 99.13%
Jun 30, 2016 26.88%
Mar 31, 2016 60.14%
Sep 30, 2015 1.65%
Jun 30, 2015 60.72%
Mar 31, 2015 56.67%
Sep 30, 2014 -218.18%
Jun 30, 2014 -121.52%
Mar 31, 2014 -339.19%
Dec 31, 2013 66.86%
Sep 30, 2013 69.94%
Jun 30, 2013 12.46%
Mar 31, 2013 31.54%
Dec 31, 2012 58.34%
Sep 30, 2012 67.39%
Jun 30, 2012 60.31%
Mar 31, 2012 31.49%
Dec 31, 2011 -117.39%
Sep 30, 2011 -215.48%